Get the Stockscreener App
2.50
0.81%
+0.02
After Hours:
2.53
0.03
+1.20%
Cronos Group Inc stock is currently priced at $2.50, with a 24-hour trading volume of 1.41M.
It has seen a +0.81% increased in the last 24 hours and a +0.40% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $2.49 pivot point. If it approaches the $2.54 resistance level, significant changes may occur.
Previous Close:
$2.48
Open:
$2.45
24h Volume:
1.41M
Market Cap:
$953.25M
Revenue:
$87.89M
Net Income/Loss:
$-73.96M
P/E Ratio:
-6.5789
EPS:
-0.38
Net Cash Flow:
$-46.26M
1W Performance:
+3.73%
1M Performance:
+0.40%
6M Performance:
+40.45%
1Y Performance:
+42.05%
1D Range:
$2.42
$2.53
52W Range:
$1.64
$2.99
Cronos Group Inc Stock (CRON) Company Profile
Name
Cronos Group Inc
Sector
Phone
416-504-0004
Address
720 King Street West, Suite 320, Toronto, ON
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-28-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-11-22 | Upgrade | CIBC | Neutral → Sector Outperform |
| Mar-22-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-27-22 | Upgrade | Jefferies | Underperform → Hold |
| Nov-18-21 | Resumed | BofA Securities | Underperform |
| Apr-28-21 | Resumed | BofA Securities | Underperform |
| Feb-22-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-24-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-27-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-14-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-02-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-31-20 | Downgrade | Canaccord Genuity | Hold → Sell |
| Mar-04-20 | Upgrade | MKM Partners | Neutral → Buy |
| Mar-03-20 | Downgrade | Stifel | Buy → Hold |
| Oct-18-19 | Upgrade | Stifel | Hold → Buy |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-05-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Aug-13-19 | Initiated | Piper Jaffray | Overweight |
| Aug-09-19 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-28-19 | Initiated | Consumer Edge Research | Equal Weight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Upgrade | BofA/Merrill | Underperform → Buy |
| Apr-17-19 | Initiated | BofA/Merrill | Underperform |
| Mar-27-19 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-25-19 | Initiated | Jefferies | Underperform |
| Jan-18-19 | Initiated | CIBC | Sector Outperform |
View All
Cronos Group Inc Stock (CRON) Latest News
Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024
GlobeNewswire Inc.
Why Marijuana Stocks Got Burnt Today
The Motley Fool
NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?
Benzinga
Why Canopy Growth, Cronos, and Aurora Cannabis Stocks Popped on Monday
The Motley Fool
Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
Benzinga
Why Canadian Marijuana Stocks Popped Today
The Motley Fool
Cronos Group Inc Stock (CRON) Financials Data
Cronos Group Inc (CRON) Revenue 2024
CRON reported a revenue (TTM) of $87.89 million for the quarter ending December 31, 2023, a -1.33% decline year-over-year.
Cronos Group Inc (CRON) Net Income 2024
CRON net income (TTM) was -$73.96 million for the quarter ending December 31, 2023, a +56.17% increase year-over-year.
Cronos Group Inc (CRON) Cash Flow 2024
CRON recorded a free cash flow (TTM) of -$46.26 million for the quarter ending December 31, 2023, a +50.78% increase year-over-year.
Cronos Group Inc (CRON) Earnings per Share 2024
CRON earnings per share (TTM) was -$0.1843 for the quarter ending December 31, 2023, a +59.04% growth year-over-year.
About Cronos Group Inc
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.
2.03%
4.37%
Cap:
|
Volume (24h):